Jyoti Roy

447 total citations
18 papers, 360 citations indexed

About

Jyoti Roy is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jyoti Roy has authored 18 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jyoti Roy's work include Cancer, Hypoxia, and Metabolism (5 papers), Peptidase Inhibition and Analysis (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Jyoti Roy is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Peptidase Inhibition and Analysis (5 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Jyoti Roy collaborates with scholars based in United States, India and Germany. Jyoti Roy's co-authors include Philip S. Low, Karson S. Putt, Suraj U. Hettiarachchi, Madduri Srinivasarao, Xiaoliang Liang, Ananda Kumar Kanduluru, Mark Cushman, Konstantin Tsoyi, Wei Lv and Cheryl Nickerson‐Nutter and has published in prestigious journals such as Nature, Journal of Medicinal Chemistry and Science Translational Medicine.

In The Last Decade

Jyoti Roy

17 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jyoti Roy United States 11 136 130 103 90 56 18 360
Yvonne H. W. Derks Netherlands 11 170 1.3× 105 0.8× 213 2.1× 197 2.2× 78 1.4× 16 479
Haofan Wang China 10 97 0.7× 186 1.4× 61 0.6× 58 0.6× 35 0.6× 19 392
Theodoros Karampelas Greece 11 96 0.7× 172 1.3× 48 0.5× 29 0.3× 38 0.7× 17 377
Alfonso Serrano del Valle Spain 6 168 1.2× 159 1.2× 49 0.5× 38 0.4× 49 0.9× 9 466
Eric M. Sievers United States 8 96 0.7× 75 0.6× 85 0.8× 103 1.1× 42 0.8× 8 399
Takeshi Hirata Japan 14 76 0.6× 127 1.0× 214 2.1× 44 0.5× 118 2.1× 38 507
Meeri Käkelä Finland 12 64 0.5× 125 1.0× 75 0.7× 137 1.5× 23 0.4× 22 326
Amy Buckley Ireland 8 117 0.9× 265 2.0× 76 0.7× 42 0.5× 74 1.3× 16 533
Alexis S. Lopez United States 6 170 1.3× 226 1.7× 98 1.0× 27 0.3× 74 1.3× 8 495
Ohad Ilovich United States 14 110 0.8× 223 1.7× 108 1.0× 147 1.6× 80 1.4× 26 538

Countries citing papers authored by Jyoti Roy

Since Specialization
Citations

This map shows the geographic impact of Jyoti Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jyoti Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jyoti Roy more than expected).

Fields of papers citing papers by Jyoti Roy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jyoti Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jyoti Roy. The network helps show where Jyoti Roy may publish in the future.

Co-authorship network of co-authors of Jyoti Roy

This figure shows the co-authorship network connecting the top 25 collaborators of Jyoti Roy. A scholar is included among the top collaborators of Jyoti Roy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jyoti Roy. Jyoti Roy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Huang, Shan, Ling Ren, Jessica A. Beck, et al.. (2023). Exploration of Imaging Biomarkers for Metabolically-Targeted Osteosarcoma Therapy in a Murine Xenograft Model. Cancer Biotherapy and Radiopharmaceuticals. 38(7). 475–485. 3 indexed citations
2.
Phelps, Tim E., Jyoti Roy, Michael V. Green, et al.. (2021). Sodium Fluoride-18 and Radium-223 Dichloride Uptake Colocalize in Osteoblastic Mouse Xenograft Tumors. Cancer Biotherapy and Radiopharmaceuticals. 36(2). 133–142. 5 indexed citations
3.
Roy, Jyoti, Elaine M. Jagoda, Falguni Basuli, et al.. (2021). In Vitro and In Vivo Comparison of 3,2-HOPO Versus Deferoxamine-Based Chelation of Zirconium-89 to the Antimesothelin Antibody Anetumab. Cancer Biotherapy and Radiopharmaceuticals. 36(4). 316–325. 12 indexed citations
4.
Roy, Jyoti, Falguni Basuli, Ana Christina L. Opina, et al.. (2021). Monitoring PSMA Responses to ADT in Prostate Cancer Patient-Derived Xenograft Mouse Models Using [18F]DCFPyL PET Imaging. Molecular Imaging and Biology. 23(5). 745–755. 5 indexed citations
5.
Hettiarachchi, Suraj U., Jyoti Roy, Fenghua Zhang, et al.. (2020). Targeted inhibition of PI3 kinase/mTOR specifically in fibrotic lung fibroblasts suppresses pulmonary fibrosis in experimental models. Science Translational Medicine. 12(567). 69 indexed citations
6.
Roy, Jyoti, Blake M. Warner, Falguni Basuli, et al.. (2020). Comparison of Prostate-Specific Membrane Antigen Expression Levels in Human Salivary Glands to Non-Human Primates and Rodents. Cancer Biotherapy and Radiopharmaceuticals. 35(4). 284–291. 25 indexed citations
7.
Roy, Jyoti, et al.. (2020). Design and validation of fibroblast activation protein alpha targeted imaging and therapeutic agents. Theranostics. 10(13). 5778–5789. 55 indexed citations
8.
Roy, Jyoti, Frank C. Kuo, Falguni Basuli, et al.. (2019). The Distribution Volume of 18 F-Albumin as a Potential Biomarker of Antiangiogenic Treatment Efficacy. Cancer Biotherapy and Radiopharmaceuticals. 34(4). 238–244. 1 indexed citations
9.
Roy, Jyoti, et al.. (2019). Small molecule targeted NIR dye conjugate for imaging LHRH receptor positive cancers. Oncotarget. 10(2). 152–160. 11 indexed citations
10.
Roy, Jyoti, et al.. (2018). Targeted Tubulysin B Hydrazide Conjugate for the Treatment of Luteinizing Hormone-Releasing Hormone Receptor-Positive Cancers. Bioconjugate Chemistry. 29(7). 2208–2214. 8 indexed citations
11.
Low, Stewart A., Chris V. Galliford, Yava Jones‐Hall, et al.. (2017). Healing Efficacy of fracture-targeted GSK3β inhibitor-loaded Micelles for Improved Fracture Repair. Nanomedicine. 12(3). 185–193. 16 indexed citations
12.
Roy, Jyoti, et al.. (2016). Evaluation of Nonpeptidic Ligand Conjugates for the Treatment of Hypoxic and Carbonic Anhydrase IX–Expressing Cancers. Molecular Cancer Therapeutics. 16(3). 453–460. 12 indexed citations
13.
Roy, Jyoti, et al.. (2016). Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors. Molecular Pharmaceutics. 13(5). 1618–1625. 34 indexed citations
14.
Roy, Jyoti, Karson S. Putt, Domenico Coppola, et al.. (2016). Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue. Oncotarget. 7(12). 14605–14615. 33 indexed citations
15.
Roy, Jyoti, Ananda Kumar Kanduluru, Venkatesh Chelvam, et al.. (2015). DUPA Conjugation of a Cytotoxic Indenoisoquinoline Topoisomerase I Inhibitor for Selective Prostate Cancer Cell Targeting. Journal of Medicinal Chemistry. 58(7). 3094–3103. 39 indexed citations
16.
Roy, Jyoti, et al.. (2015). Selective Tumor Targeting of Desacetyl Vinblastine Hydrazide and Tubulysin B via Conjugation to a Cholecystokinin 2 Receptor (CCK2R) Ligand. Molecular Pharmaceutics. 12(7). 2477–2483. 26 indexed citations
17.
Levin, Mark, et al.. (1996). Translocation (3;3) in a patient with thrombocytopenia and erythroid dysplasia. Cancer Genetics and Cytogenetics. 87(1). 11–13.
18.
Roy, Jyoti, R. R. Brown, & J. M. Price. (1959). 8-Hydroxyquinaldic Acid: the Red Fluorescent Substance in the Urine of Pyridoxine-Deficient Rats. Nature. 184(4698). 1573–1574. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yvonne H. W. Derks Breakdown of academic impact, for papers by Haofan Wang Breakdown of academic impact, for papers by Theodoros Karampelas Breakdown of academic impact, for papers by Alfonso Serrano del Valle Breakdown of academic impact, for papers by Eric M. Sievers Breakdown of academic impact, for papers by Takeshi Hirata Breakdown of academic impact, for papers by Meeri Käkelä Breakdown of academic impact, for papers by Amy Buckley Breakdown of academic impact, for papers by Alexis S. Lopez Breakdown of academic impact, for papers by Ohad Ilovich
Rankless by CCL
2026